Verona Pharma Plc - ADR


Market Cap$867.95M

Compare Verona Pharma Plc - ADR

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Verona Pharma Plc - ADRVerona Pharma Plc - ADR-17.10%-19%-0.1
marketMarket Avg49.51.28%13%6.20.1
HealthcareHealthcare Avg31.91.26%18%7.50.9

Current Fair Value

16.1% upside

Undervalued by 16.1% based on the discounted cash flow analysis.

Share Statistics

Market cap$867.95 Million
Enterprise Value$630.89 Million
Dividend Yield$0.0 (0.0%)
Earnings per Share$-0.08
Outstanding Shares51,818,199
Avg 30 Day Volume476,876


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-17.12
Price to Sales-
Price to Book Ratio3.36
Enterprise Value to Revenue1377.49
Enterprise Value to EBIT-10.07
Enterprise Value to Net Income-13
Total Debt to Enterprise0.03
Debt to Equity0.08

Revenue Sources

No data

ESG Score

No data

About Verona Pharma Plc

CEO: David Zaccardelli